Suppr超能文献

美国食品药品监督管理局对食品添加剂不良反应的监测。

Monitoring adverse reactions to food additives in the U.S. Food and Drug Administration.

作者信息

Tollefson L

机构信息

Office of Nutrition and Food Sciences, U.S. Food and Drug Administration, Washington, DC 20204.

出版信息

Regul Toxicol Pharmacol. 1988 Dec;8(4):438-46. doi: 10.1016/0273-2300(88)90044-x.

Abstract

Technological advances in food science have resulted in the development of numerous food additives, most of which require premarket approval by the Food and Drug Administration (FDA). Concomitant with the benefits of these additives, such as extending the shelf life of certain food commodities, is the potential for various risks. These potential risks include the possibility of the consumer experiencing an adverse reaction to the additive. In order to ascertain the character and the gravity of alleged adverse reactions to food products which it regulates, the FDA's Center for Food Safety and Applied Nutrition has developed the Adverse Reaction Monitoring System (ARMS). This postmarketing surveillance system for food additives is designed to analyze consumer reports of adverse reactions in order to alert FDA officials about any potential public health hazard associated with an approved food additive, and to delineate specific syndromes which may lead to focused clinical investigations. To date, among the products routinely monitored in the ARMS, sulfiting agents and the artificial sweetener aspartame have generated the largest volume of consumer reports describing adverse reactions. An overview of the analyses of the sulfite and aspartame adverse reaction reports is presented, along with a description of the mechanics of the postmarketing surveillance system, and a detailed discussion of its limitations.

摘要

食品科学领域的技术进步催生了众多食品添加剂,其中大多数需要获得美国食品药品监督管理局(FDA)的上市前批准。与这些添加剂带来的益处(如延长某些食品的保质期)相伴而来的是各种潜在风险。这些潜在风险包括消费者可能对添加剂产生不良反应。为了确定其所监管的食品 alleged 不良反应的性质和严重程度,FDA 的食品安全与应用营养中心开发了不良反应监测系统(ARMS)。这个针对食品添加剂的上市后监测系统旨在分析消费者关于不良反应的报告,以便就与已批准食品添加剂相关的任何潜在公共卫生危害向 FDA 官员发出警报,并确定可能引发重点临床调查的特定症状。迄今为止,在 ARMS 常规监测的产品中,亚硫酸盐类制剂和人工甜味剂阿斯巴甜引发的消费者描述不良反应的报告数量最多。本文概述了亚硫酸盐和阿斯巴甜不良反应报告的分析情况,介绍了上市后监测系统的运行机制,并详细讨论了其局限性。

原文中“alleged”疑似拼写有误,结合语境推测可能是“actual”实际的意思,翻译时暂按推测翻译,你可根据实际情况调整。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验